Reduced expression of endogenous secretory receptor for advanced glycation endproducts in hippocampal neurons of Alzheimer's disease brains
Authors:
Open Access
- 1 January 2007
- journal article
- Published by International Society of Histology & Cytology in Archives of Histology and Cytology
- Vol. 70 (5) , 279-290
Abstract
The receptor for advanced glycation endproducts (RAGE) is a cell-surface multiligand receptor, which interacts with amyloid β (Aβ), a key protein in Alzheimer's disease (AD). RAGE-Aβ interaction is thought to be associated with pathological progression in AD. A splice variant of RAGE, endogenous secretory RAGE (esRAGE) can act as a decoy receptor for RAGE ligands that would prevent the progression of some pathologic conditions. In this study, the expression of esRAGE in the hippocampal tissues from AD brains compared with control (non-AD) was examined by immunohistochemistry and Western blot analysis. Semiquantitative immunohistochemical analysis of hippocampal tissues using esRAGE-specific antibody revealed significantly decreased immunoreactivities in pyramidal cells in CA1 and CA3 regions of AD compared with non-AD. On the other hand, immunoreactivities of astrocytes for esRAGE significantly increased in those regions. Dentate granule cells and astrocytes showed essentially invariant immunoreactivities between AD and non-AD. Changes in esRAGE immunoreactivity in CA3 neurons and astrocytes were observed from the early pathological stages. Moreover, the esRAGE-immunoreactive bands of AD samples were weaker than those of non-AD samples in Western blot analysis. The results indicate that low expression of esRAGE in the hippocampus would be associated with the development of AD.Keywords
This publication has 27 references indexed in Scilit:
- Identification of mouse orthologue of endogenous secretory receptor for advanced glycation end-products: structure, function and expressionBiochemical Journal, 2006
- Plasma Level of Endogenous Secretory RAGE Is Associated With Components of the Metabolic Syndrome and AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Purification and Characterization of Mouse Soluble Receptor for Advanced Glycation End Products (sRAGE)Journal of Biological Chemistry, 2004
- Hippocampal neurons in pre-clinical Alzheimer’s diseaseNeurobiology of Aging, 2004
- RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brainNature Medicine, 2003
- Receptor for Advanced Glycation End Products (RAGE)-mediated Neurite Outgrowth and Activation of NF-κB Require the Cytoplasmic Domain of the Receptor but Different Downstream Signaling PathwaysJournal of Biological Chemistry, 1999
- RAGE Mediates a Novel Proinflammatory AxisCell, 1999
- RAGE and amyloid-β peptide neurotoxicity in Alzheimer's diseaseNature, 1996
- Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991